Heparins and heparin–induced thrombocytopenia

    Research output: Chapter in Book/Report/Conference proceedingChapter

    1 Citation (Scopus)

    Abstract

    This chapter discussed the pharmacology and use of the heparins–standard heparin, low molecular weight heparin, and fondaparinux. The complication of heparin–induced thrombocytopenia is also discussed. Heparin functions as an antithrombotic agent by binding antithrombin (AT), promoting inactivation of the active serine proteases involved in blood coagulation (factors IIa, VIIa–TF, IXa, Xa, and XIa). Heparin is a blend of saccharide polymers ranging in molecular weight from 3 to 30,000 Da. A specific pentasaccharide sequence is required for promoting AT activity. This sequence is found in only one–third of the heparin molecules in the heparin currently used. Other polymers found in heparin may have platelet–inhibitory effects or fibrinolytic effects.

    Original languageEnglish (US)
    Title of host publicationHemostasis and Thrombosis, Third Edition
    PublisherSpringer International Publishing
    Pages111-115
    Number of pages5
    ISBN (Print)9783319093123, 9783319093116
    DOIs
    StatePublished - Jan 1 2015

    Fingerprint

    Thrombocytopenia
    Heparin
    Antithrombins
    Polymers
    Blood Coagulation Factors
    Fibrinolytic Agents
    Low Molecular Weight Heparin
    Serine Proteases
    Molecular Weight
    Pharmacology

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Deloughery, T. (2015). Heparins and heparin–induced thrombocytopenia. In Hemostasis and Thrombosis, Third Edition (pp. 111-115). Springer International Publishing. https://doi.org/10.1007/978-3-319-09312-3_22

    Heparins and heparin–induced thrombocytopenia. / Deloughery, Thomas.

    Hemostasis and Thrombosis, Third Edition. Springer International Publishing, 2015. p. 111-115.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Deloughery, T 2015, Heparins and heparin–induced thrombocytopenia. in Hemostasis and Thrombosis, Third Edition. Springer International Publishing, pp. 111-115. https://doi.org/10.1007/978-3-319-09312-3_22
    Deloughery T. Heparins and heparin–induced thrombocytopenia. In Hemostasis and Thrombosis, Third Edition. Springer International Publishing. 2015. p. 111-115 https://doi.org/10.1007/978-3-319-09312-3_22
    Deloughery, Thomas. / Heparins and heparin–induced thrombocytopenia. Hemostasis and Thrombosis, Third Edition. Springer International Publishing, 2015. pp. 111-115
    @inbook{c100dcc59e5c485391986c1e68c1bdaf,
    title = "Heparins and heparin–induced thrombocytopenia",
    abstract = "This chapter discussed the pharmacology and use of the heparins–standard heparin, low molecular weight heparin, and fondaparinux. The complication of heparin–induced thrombocytopenia is also discussed. Heparin functions as an antithrombotic agent by binding antithrombin (AT), promoting inactivation of the active serine proteases involved in blood coagulation (factors IIa, VIIa–TF, IXa, Xa, and XIa). Heparin is a blend of saccharide polymers ranging in molecular weight from 3 to 30,000 Da. A specific pentasaccharide sequence is required for promoting AT activity. This sequence is found in only one–third of the heparin molecules in the heparin currently used. Other polymers found in heparin may have platelet–inhibitory effects or fibrinolytic effects.",
    author = "Thomas Deloughery",
    year = "2015",
    month = "1",
    day = "1",
    doi = "10.1007/978-3-319-09312-3_22",
    language = "English (US)",
    isbn = "9783319093123",
    pages = "111--115",
    booktitle = "Hemostasis and Thrombosis, Third Edition",
    publisher = "Springer International Publishing",

    }

    TY - CHAP

    T1 - Heparins and heparin–induced thrombocytopenia

    AU - Deloughery, Thomas

    PY - 2015/1/1

    Y1 - 2015/1/1

    N2 - This chapter discussed the pharmacology and use of the heparins–standard heparin, low molecular weight heparin, and fondaparinux. The complication of heparin–induced thrombocytopenia is also discussed. Heparin functions as an antithrombotic agent by binding antithrombin (AT), promoting inactivation of the active serine proteases involved in blood coagulation (factors IIa, VIIa–TF, IXa, Xa, and XIa). Heparin is a blend of saccharide polymers ranging in molecular weight from 3 to 30,000 Da. A specific pentasaccharide sequence is required for promoting AT activity. This sequence is found in only one–third of the heparin molecules in the heparin currently used. Other polymers found in heparin may have platelet–inhibitory effects or fibrinolytic effects.

    AB - This chapter discussed the pharmacology and use of the heparins–standard heparin, low molecular weight heparin, and fondaparinux. The complication of heparin–induced thrombocytopenia is also discussed. Heparin functions as an antithrombotic agent by binding antithrombin (AT), promoting inactivation of the active serine proteases involved in blood coagulation (factors IIa, VIIa–TF, IXa, Xa, and XIa). Heparin is a blend of saccharide polymers ranging in molecular weight from 3 to 30,000 Da. A specific pentasaccharide sequence is required for promoting AT activity. This sequence is found in only one–third of the heparin molecules in the heparin currently used. Other polymers found in heparin may have platelet–inhibitory effects or fibrinolytic effects.

    UR - http://www.scopus.com/inward/record.url?scp=84944618605&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84944618605&partnerID=8YFLogxK

    U2 - 10.1007/978-3-319-09312-3_22

    DO - 10.1007/978-3-319-09312-3_22

    M3 - Chapter

    AN - SCOPUS:84944618605

    SN - 9783319093123

    SN - 9783319093116

    SP - 111

    EP - 115

    BT - Hemostasis and Thrombosis, Third Edition

    PB - Springer International Publishing

    ER -